Side Effects of Antidepressants, Antipsychotics, Psychostimulants, Hypnotics and More

Psychiatric Drugs that Cause Violence

Your Friend — Tue, 08 Feb 2011 18:25:59 +0000

If you keep up with the news you are already aware that many psychiatric drugs cause violence, suicide and multiple side effects. Well, now Mercola has published a list of specific drugs known to cause violence. It is not speculation anymore! A matter of fact some of the drug studies revealed this problem early on, prior to the marketing of the drug, yet it was released and is still on the market.

Meanwhile, here is a list of the drugs:

10. Desvenlafaxine (Pristiq): An antidepressant which affects both serotonin and noradrenaline

9. Venlafaxine (Effexor): An antidepressant also used to treat anxiety disorders

8. Fluvoxamine (Luvox): Another SSRI antidepressant

7. Triazolam (Halcion): This potentially addictive drug is used to treat insomnia

6. Atomoxetine (Strattera): An ADHD drug that affects the neurotransmitter noradrenaline

5. Mefoquine (Lariam): A treatment for malaria which is often linked with reports of strange behavior

4. Amphetamines: (Various): Used to treat ADHD

3. Paroxetine (Paxil): Another SSRI antidepressant, Paxil is also linked with severe withdrawal symptoms and a risk of birth defects

2. Fluoxetine (Prozac): This drug was the first well-known SSRI antidepressant

1. Varenicline (Chantix): The number one violence-inducing drug on the list, this anti-smoking medication is 18 times more likely to be linked with violence when compared to other drugs

Find natural alternatives, turn to your faith and/or deal with the stress in your life or in your past. Do not risk your health, your life or the lives of your family and friends!

Abilify (Aripiprazole) Side Effects

Your Friend — Fri, 25 Jun 2010 19:42:17 +0000

Abilify, which is the brand name for aripiprazole, is an antipsychotic medication used to treat bipolar disorder, schizophrenia, manic depression, major depression and now autism, and many others. Abilify has been all over the news. The side effects can be life threatening. The FDA has issued warnings that Abilify can lead to Leukopenia, Neutropenia and agranulocytosis, (all abnormal lowering of the white blood cell count). The list of adverse reactions and warnings keep mounting.

Abilify Side Effects include, but not limited to:

Confusion

Fast heart rate (tachycardia)

High fever

Irregular heart rhythms (arrhythmias)

Irregular pulse or blood pressure

Stiff muscles

Sweating

Akathesia (a movement disorder characterized by a feeling of inner restlessness and a compelling need to be in constant motion)

Weight gain

Leukemia

and more

There is an FDA warning that Abilify used in the elderly can be fatal. Abilify increases the risk of stroke and fatal heart attacks in those with dementia.

PRECAUTIONS

and Agranulocytosis

In 2009 the FDA reported,

Class Effect: In clinical trial and/or postmarketing experience, events of leukopenia/neutropenia have been reported temporally related to antipsychotic agents, including Abilify. Agranulocytosis has also been reported.
Possible risk factors for leukopenia/neutropenia include pre-existing low white blood cell count (WBC) and history of drug-induced leukopenia/neutropenia. Patients with a history of a clinically significant low WBC or drug-induced leukopenia/neutropenia should have their complete blood count (CBC) monitored frequently during the first few months of therapy and discontinuation of Abilify should be considered at the first sign of a clinically significant decline in WBC in the absence of other causative factors.
Patients with clinically significant neutropenia should be carefully monitored for fever or other symptoms or signs of infection and treated promptly if such symptoms or signs occur. Patients with severe neutropenia (absolute neutrophil count <1000/mm3) should discontinue Abilify and have their WBC followed until recovery.

Report all adverse reactions to any drug to the FDA MedWatch.

Seroquel (Quetiapine Fumarate) Lawsuit

Your Friend — Mon, 21 Jun 2010 19:51:56 +0000

Seroquel, manufactured by AstraZeneca, is an oral medication used to
manage the symptoms associated with schizophrenia such as delusions, thought disorder, hallucinations, social withdrawal, lack of energy,
apathy, and reduced ability to express emotion.

The drug, which was approved by the FDA for marketing in 1997, affects
a broad range of neurotransmitter receptors, including serotonin
receptors. It is also sometimes used to treat the mania associated
with bipolar disorder.

News of Seroquel’s side effects and emerged as a result of observational
data released at a medical conference in Philadelphia which showed that
patients on Seroquel had 3.34 times as many cases of diabetes as those
on older antipsychotics such as haldoperidol.

Towards the end of August, 2003, news of side effects associated with
Seroquel became widely publicized and caused the value of
AstraZeneca’s stock to decrease by almost one percent.

Soon after, the law firms of Parker & Waichman and Aylstock, Witkens &
Sasser announced that a class action lawsuit had been commenced in the
United States District Court for the Middle District of Florida on behalf of
all those who had used Seroquel.

This lawsuit contends that AstraZeneca was aware that Seroquel was
associated with a high occurrence of diabetes, but they did not take steps
to adequately warn doctors or patients in the United States of this
potential risk.

The pending lawsuit seeks statutory, exemplary and punitive financial
damages from AstraZeneca for their alleged disregard of the well being
and health of the plaintiffs and class members (the people who took
Seroquel and subsequently developed diabetes).

In addition, the lawsuit also alleges that AstraZeneca aggressively
marketed and promoted Seroquel for “off label” use that was beyond
its FDA approved indications at the time in question.

AstraZeneca is accused of unfairly offering incentives to doctors and
other medical professionals in an effort to increase the number of
Seroquel prescriptions that were written.

The Seroquel class action lawsuit seeks to establish a medical monitoring
fund to pay for anyone who has taken Seroquel so that they can be tested
for diabetes and other blood sugar disorders.

On January 30th, 2004, AstraZeneca Pharmaceuticals LP, the company
that markets Seroquel in the United States sent a “Dear Doctor” letter
to thousands of doctors throughout the USA. The letter indicated that:

“…Hyperglycemia, in some cases extreme and associated with
ketoacidosis or hyperosmolar coma or death, has been reported in
patients treated with atypical antipsychotics, including Seroquel.”
[Click Here to read the actual Seroquel "Dear Doctor" letter]

Risperdal (Risperidone) Lawsuit

Your Friend — Mon, 21 Jun 2010 19:50:07 +0000

Risperdal, which is manufactured by Janssen Pharmaceuticals, a division
of Johnson & Johnson, is another member of the family of drugs knows
as Atypical Antipsychotics.

Risperdal has been linked to diabetes and, more specifically, Type 2
diabetes. (Type 2 diabetes is sometimes called adult-onset diabetes.
Type 2 diabetes is associated with an increased risk of heart disease
and stroke)

Other serious side effects, however, include Neuroleptic Malignant
Syndrome (NMS), Tardive Dyskinesia, stroke or stroke-like events,
and even death. (NMS is a potentially fatal syndrome involving
muscle rigidity, and irregular blood pressure and pulse).

Tardive Dyskinesia is a central nervous system disorder, which results in
involuntary movement of the limbs and twitching of the face and tongue.)

Although it is primarily used for treating schizophrenia, Risperdal is also
used to control other behavioral disorders in elderly patients ( such as
nursing home patients) who have delusions, aggression, and anxiety
as is often seen in patients with Alzheimer’s disease and/or dementia.

Risperdal has also been under scrutiny for causing severe side effects and
adverse reactions mentioned above.

Although Risperdal was approved by the FDA in 1994, it took some time
before the dangerous side effects were completely identified though a
series of studies.

On April 11^thof 2003 Johnson & Johnson sent “Dear Doctor” letters to
thousands of physicians in the United States advising them of the
possible risk of stroke among elderly patients taking Risperdal.

The letter indicated that Johnson and Johnson had modified the Risperdal
label so that practitioners were aware that:

… ” there was a significantly higher incidence of cerebrovascular adverse
events in patients treated with risperidone compared to patients treated
with placebo. RISPERDAL has not been shown to be safe or effective in the
treatment of patients with dementia-related psychosis ” [ Click Here to
read the actual Risperdal "Dear Practitioner letter" ].

This came after Johnson & Johnson had received 37 reports of stroke or
related events like blood clots or hemorrhages, including 16 deaths.

As a result of these findings, Johnson & Johnson updated the warning label
on Risperdal to include more specific information about strokes in the
elderly. At this time it became apparent that Risperdal should not be used
to treat dementia because there is no evidence that it is safe or effective
in that capacity.

Risperdal has also been known to cause irregular headaches, muscle
weakness and spasms, high fever, constipation, weight gain, and
headaches.

People on Risperdal who have any or all of these side effects should
contact their doctor and discuss these problems with their doctor because
these conditions may be warning signs of serious illness.

SOURCE: http://www.coreynahman.com/atypical-antipsychotic-lawsuits.html

Zyprexa Lawsuit

Your Friend — Mon, 21 Jun 2010 19:47:19 +0000

Atypical Anti-Psychotic Drug Lawsuits

Zyprexa (Olanzapine®) Lawsuit

Zyprexa, like Risperdal and Seroquel, has been associated with serious
side effects in patients, especially those who have already been
diagnosed with diabetes.

Knowledge of the potential dangers of Zyprexa were discovered as a
result of a series of findings beginning in 2001 when the FDA was alerted
to 19 case reports of diabetes associated with the drug.

One of these cases resulted in a patient’s death due to necrotizing
pancreatitis, a very serious condition in which cells in the pancreas
die.

An emergency report issued by the Japanese Health and Welfare Ministry
in April of 2002 concerning the side effects of Zyprexa noted that there
had been two deaths of patients who had diabetes prior to taking the
anti-psychotic medication.

It also reported that there had been seven other patients who lost
consciousness or slipped into comas after taking the drug.

In April of 2003, the Wall Street Journal ran a front page article on
Zyprexa and the other Atypical Antipsychotics with respect to their
connection to cases of Type 2 Diabetes ( sometimes called “adult
onset diabetes”).

The authors of the Wall Street Journal article estimated that somewhere
around 11 million people have taken Zyprexa. An eight-year study found
that nearly 300 patients developed diabetes, 75 became seriously ill, and
23 died.

In addition to the Wall Street Journal article, five lawsuits were filed
against Eli Lilly and Co. accusing the company of failing to warn Zyprexa
patients of the risk that Zyprexa caused the patients’ diabetes.

The plaintiffs are seeking damages of up to $35 million. In order to
confront the charges, Lilly sponsored two patient trials and opened its files
of Zyprexa patients to an outside researcher to study the issue.

The lawsuits claim that Lilly knew that the product was dangerous and
unsafe and that it never took the necessary steps to provide this critical
information to medical professionals or patients.

Finally, in May of 2003 forty reports of hyperglycemia (elevated blood
sugar), diabetes mellitus, or exacerbation of diabetes were received
in the UK including one which proved to be fatal.

In March of 2004, Eli Lilly ( the company that markets Zyprexa in the
United States) sent a so call “Dear Doctor Letter” to thousands of
physicians who were likely to use Zyprexa.

The letter indicated that Lilly was adding a warning statement to the
Zyprexa label regarding the increased risk of hyperglycemia and diabetes
in people taking Zyprexa and similar medicines. [Click Here to read the
actual warning letter]

SOURCE: http://www.coreynahman.com/atypical-antipsychotic-lawsuits.html

Mayo Clinic on Alternatives for Major Depression

Your Friend — Fri, 05 Mar 2010 20:56:30 +0000

To my surprise, The Mayo Clinic is advising alternative treatments for major depression. I list their suggestions below:

St. John’s wort - an herb supplement; one site suggested 300 mg per day for mild or moderate depression.

SAMe. (pronounced “sammy”) – a synthetic supplement (not natural); not approved in the U.S., but in Europe.

Omega-3 fatty acids – from food or supplements.

The Mayo Clinic reminds us that supplements are monitored by the FDA (Food and Drug Administration) just as medicines are monitored.

Some of their suggestions for mind body techniques are listed below:

Acupuncture

Yoga

Meditation

Massage therapy

SOURCE: http://www.mayoclinic.com/health/depression/DS00175/DSECTION=alternative-medicine

Dr. Oz on Valerian Root for Anxiety

Your Friend — Fri, 26 Feb 2010 20:26:54 +0000

On yesterday’s episode, February 25, 2009, of the Dr. Oz Show, per Gluten Free Carla’s Blog, Dr. Oz stated that Valerian Root works on the brain and is good for anxiety.

Has anyone tried this? Please let us all know if you have. If you’re about to try it, please bookmark this page and come back and give us an update!

Fatty Acid Reduces Risk of Progression of Psychiotic Disorder and Prevention in Young

Your Friend — Thu, 04 Feb 2010 03:12:33 +0000

A Randomized, Placebo-Controlled Trial

Published in “General Psychiatry” by the American Medial Association

February 2, 2010

G. Paul Amminger, MD; Miriam R. Schäfer, MD; Konstantinos Papageorgiou, MD; Claudia M. Klier, MD; Sue M. Cotton, PhD; Susan M. Harrigan, MSc; Andrew Mackinnon, PhD; Patrick D. McGorry, MD, PhD; Gregor E. Berger, MD

Arch Gen Psychiatry. 2010;67(2):146-154.

Context The use of antipsychotic medication for the preventionof psychotic disorders is controversial. Long-chain -3 (omega-3)polyunsaturated fatty acids (PUFAs) may be beneficial in a rangeof psychiatric conditions, including schizophrenia. Given that-3 PUFAs are generally beneficial to health and without clinicallyrelevant adverse effects, their preventive use in psychosismerits investigation.
Author Affiliations: Department of Child and Adolescent Psychiatry, Medical University of Vienna, Vienna, Austria (Drs Amminger, Schäfer, Papageorgiou, and Klier); Orygen Research Centre, Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia (Drs Amminger, Cotton, Mackinnon, and McGorry and Ms Harrigan); and Department of Research and Education, The Schlössli Clinic, Oetwil am See, Switzerland (Dr Berger).

Objective To determine whether -3 PUFAs reduce the rateof progression to first-episode psychotic disorder in adolescentsand young adults aged 13 to 25 years with subthreshold psychosis.

Design Randomized, double-blind, placebo-controlled trialconducted between 2004 and 2007.

Setting Psychosis detection unit of a large public hospitalin Vienna, Austria.

Participants Eighty-one individuals at ultra-high riskof psychotic disorder.

Interventions A 12-week intervention period of 1.2-g/d-3 PUFA or placebo was followed by a 40-week monitoring period;the total study period was 12 months.

Main Outcome Measures The primary outcome measure wastransition to psychotic disorder. Secondary outcomes includedsymptomatic and functional changes. The ratio of -6 to -3 fattyacids in erythrocytes was used to index pretreatment vs posttreatmentfatty acid composition.

Results Seventy-six of 81 participants (93.8%) completedthe intervention. By study’s end (12 months), 2 of 41 individuals(4.9%) in the -3 group and 11 of 40 (27.5%) in the placebo grouphad transitioned to psychotic disorder (P = .007).The difference between the groups in the cumulative risk ofprogression to full-threshold psychosis was 22.6% (95% confidenceinterval, 4.8-40.4). -3 Polyunsaturated fatty acids also significantlyreduced positive symptoms (P = .01), negative symptoms(P = .02), and general symptoms (P = .01)and improved functioning (P = .002) compared withplacebo. The incidence of adverse effects did not differ betweenthe treatment groups.

Conclusions Long-chain -3 PUFAs reduce the risk of progressionto psychotic disorder and may offer a safe and efficacious strategyfor indicated prevention in young people with subthreshold psychoticstates.

Trial Registration clinicaltrials.gov Identifier: NCT00396643

SOURCE: http://archpsyc.ama-assn.org/cgi/content/abstract/67/2/146

The Feingold Diet Program for ADHD on BlogTalk Radio

Your Friend — Sat, 30 Jan 2010 21:26:40 +0000

Jane Hersey, the director of the Feingold Association, a non-profit organization, will be on BlogTalk Radio on Carla’s Cooking Show on Monday, February 15, 2010 at 1:30 pm PDT / 4:30 pm EDT.

Per Carla’s Cooking,

“Jane Hersey, Director of The Feingold Association and author of “What Are All Those Funny Things in Food? And Should I Eat Them?” and ”Why Can’t My Child Behave” will present eye-opening information that will provide a very basic understanding about how the food we select can affect us, including behavior and learning; astonishing information on brand foods to avoids and why; information on both harmful and healthy sugar substitutes; eating healthy on a budget; and her latest passion, how to provide our children with healthy school lunches for less money. I wish I could tell you more, but I do not want to spoil the show. Tune in!”

What is the The Feingold Diet Program?

Per the Feingold Association’s website,

“Did you know that the brand of ice cream, cookie, and potato chip you select could have a direct effect on the behavior, health, and ability to learn for you or your children?

Numerous studies show that certain synthetic food additives can have serious learning, behavior, and/or health effects for sensitive people. The Feingold Program (also known as the Feingold Diet) is a test to determine if certain foods or food additives are triggering particular symptoms. It is basically the way people used to eat before “hyperactivity” and “ADHD” became household words, and before asthma and chronic ear infections became so very common. ADHD (Attention Deficit Hyperactivity Disorder) is the term currently used to describe a cluster of symptoms typical of the child (or adult) who has excessive activity or difficulty focusing. Some of the names that have been used in the past include: Minimal Brain Damage, Minimal Brain Dysfunction (MBD), Hyperkinesis, Learning Disability, H-LD (Hyperkinesis/Learning Disability), Hyperactivity, Attention Deficit Disorder, ADD With or Without Hyperactivity. In addition to ADHD, many children and adults also exhibit one or more other problems which may include: OCD (Obsessive Compulsive Disorder), ODD (Oppositional Defiant Disorder), Bi-polar Disorder, Depression, Tourette Syndrome (TS), and Developmental Delays. These people often have food or environmental allergies. Many have a history of one or more of these physical problems: ear infections, asthma, sinus problems, bedwetting, bowel disorders, headaches/migraines, stomachaches, skin disorders, sensory deficits (extreme sensitivity to noise, lights, touch), vision deficits (the left and right eyes do not work well together, sometimes nystagmus). While all the above symptoms might be helped by the Feingold Program, generally the characteristic that responds most readily is behavior. Although the symptoms differ from one person to another, the one characteristic that seems to apply to all chemically-sensitive people is that they get upset too easily. Whether the person is 3-years-old or 33, they have a short fuse. Dr. Feingold began his work on linking diet with behavior back in the 1960′s. He soon saw that the conventional wisdom about this condition was not accurate. At that time most doctors believed that children outgrew hyperactivity, that only one child in a family would be hyperactive, and that girls were seldom affected. Parents using the Feingold Diet also saw that these beliefs were not accurate. Years later, the medical community revised their beliefs, as well. Another change in the medical community has been the increased use of medicine to address ADHD. In the 1960′s and 1970′s medicine was used with restraint, generally discontinued after a few years, and never prescribed to very young children. If there was a history of tics or other neurological disorders in a family member, a child would not be give stimulant drugs. The Feingold Association does not oppose the use of medicine, but believes that practitioners should first look for the cause(s) of the problems, rather than only address the symptoms. For example, ADHD can be the result of exposure to lead or other heavy metals; in such a case, the logical treatment would be to remove the lead, arsenic, etc. The Feingold Association believes that patients have a right to be given complete, accurate information on all of the options available in the treatment of ADHD as well as other conditions. Sometimes, the best results come from a combination of treatments. This might include using the Feingold Diet plus allergy treatments, or plus nutritional supplements, or plus a gluten-free/casein-free diet, or even Feingold + ADHD medicine. We believe that it’s useful to start with the Feingold Diet since it is fairly easy to use, not expensive, and because removing certain synthetic additives is a good idea for anyone. Used originally as a diet for allergies, improvement in behavior and attention was first noticed as a “side effect.” It is a reasonable first step to take before (or with if already begun) drug treatment for any of the symptoms listed on the Symptoms page.

The Feingold Program eliminates these additives:

Artificial (synthetic) coloring
Artificial (synthetic) flavoring
Aspartame (Nutrasweet, an artificial sweetener)
Artificial (synthetic) preservatives BHA, BHT, TBHQ

In the beginning (Stage One) of the Feingold Program, aspirin and some foods containing salicylate (Suh-LIH-Suh-Late) are eliminated. Salicylate is a group of chemicals related to aspirin. There are several kinds of salicylate, which plants make as a natural pesticide to protect themselves. Those that are eliminated are listed in the salicylate list which is included also in the Program Handbook. Most people can eventually tolerate at least some of these salicylates.You will notice this dietary program is often referred to as a program because fragrances and non-food items which contain the chemicals listed above are also eliminated.

Where do food dyes come from?

Those pretty colors that make the “fruit punch” red, the gelatin green and the oatmeal blue are made from petroleum (crude oil) which is also the source for gasoline. You will find them on the ingredient labels, listed as “Yellow No. 5,” “Red 40,” “Blue #1,” etc. The label may say “FD&C” before the number. That means “Food, Drug & Cosmetics.” When you see a number listed as “D&C” in a product, such as “D&C Red #33″ it means that this coloring is considered safe for medicine (drugs) and cosmetics, but not for food. See more about colorings.

What are artificial flavorings?

They are combinations of many chemicals, both natural and synthetic. An artificial flavoring may be composed of hundreds of separate chemicals, and there is no restriction on what a company can use to flavor food. One source for imitation vanilla flavoring (called “vanillin”) is the waste product of paper mills. Some companies built factories next to the pulp mills to turn the undesirable by-product into imitation flavoring, widely used in many cookies, candies and other foods. See more about food dyes and flavorings.

What are BHA, BHT and TBHQ?

Those initials stand for three major preservatives found in many foods, especially in the United States. Like the dyes, they are made from petroleum (crude oil). Often, they are not listed in the ingredients. These chemicals may be listed as “anti-oxidants” because they prevent the fats in foods from “oxidizing” or becoming rancid (spoiling). There are many natural, beneficial anti-oxidants, but they are much more expensive than the synthetic versions. There are other undesirable food additives (MSG, sodium benzoate, nitrites, sulfites, to name a few) but most of the additives used in foods have not been found to be as big a problem as those listed above. See more about these preservatives.

What the child growing up in the U.S. in the 1940′s got:	What the child growing up in the U.S. today gets:
White toothpaste	Multi-colored toothpaste, perhaps with sparkles
Oatmeal	Sea Treasures Instant Oatmeal (turns milk blue)
Corn flakes	Fruity Pebbles
Toast & butter, jam	Pop Tarts
Cocoa made with natural ingredients	Cocoa made with artificial flavoring, & some with dyes.
Whipped cream	Cool Whip
No vitamins (or perhaps cod liver oil)	Flintstone vitamins with coloring & flavoring
White powder or bad-tasting liquid medicine	Bright pink, bubble-gum flavored chewable or liquid medicine
Sample school lunch: Meat loaf, freshly made mashed potatoes, vegetable. Milk, cupcake made from scratch.	Sample school lunch: Highly processed foods loaded with synthetic additives, no vegetable. Chocolate milk with artificial flavor.
Sample school beverage: Water from the drinking fountain	Sample school beverage: Soft drink with artificial color, flavor, caffeine, aspartame, etc.
Candy in the classroom a few times a year at class parties.	Candy (with synthetic additives) given frequently”

Sources: http://www.feingold.org/pg-overview.html

Side Effects of Prozac and Paxil for Breastfeeding Mothers

Your Friend — Fri, 29 Jan 2010 04:56:34 +0000

I remember when pregnancy meant not taking any drugs; not even aspirin; not even allergy medicine. Since when is it okay to take SSRIs before or during pregnancy? The article below explains a new study on how Paxil and Prozac and other SSRIs can negatively affect milk production in lactating (breastfeeding) women.

“Taking Prozac, Paxil, or other antidepressants from the class of drugs called selective serotonin reuptake inhibitors (SSRIs) can cause delays in lactation in new mothers and difficulty in breast-feeding newborns, a new study says.

Researchers from the University of Cincinnati found SSRIs can result in delayed secretory activiation after giving birth. SSRIs regulate the hormone serotonin in the body to stave off depression, but the hormone also is crucial to the breasts’ ability to deliver milk when it is needed, the study’s authors said.

A delay in breast milk production caused by taking SSRIs can “impact serotonin regulation in the breast, placing new mothers at greater risk of a delay in the establishment of a full milk supply,” the study found.

The study’s findings are troubling because millions of people take Prozac, Paxil, and other brands of SSRIs to treat a variety of depression-related disorders. Paxil and other SSRI drugs have been linked before to other serious health complications, including heart-related birth defects and pre-term labor.

Study of Lactating Women on SSRIs

For the study, researchers examined the effects of SSRI drugs on lactation in laboratory research using human subjects and mice. They also evaluated the effect of SSRIs in 431 new mothers and found the median onset of lactation was 85.8 hours after birth among those who used SSRIs, compared with 69.1 hours for those who weren’t taking the drugs, according to a HealthDay report.

Women who begin lactation more than 72 hours after birth are said to have developed delayed secretory activation.

The study’s authors said since many women have come to depend on SSRIs to treat depression disorders before and during pregnancy and the drugs can be effective in bringing relief from symptoms, they are not recommending women avoid taking the drugs during breast feeding. More study is needed to refine the findings and make more specific recommendations on SSRI use in breast-feeding women, the authors said.”

SOURCE: http://www.attorneyatlaw.com/2010/01/prozac-and-paxil-can-cause-breast-feeding-problems-new-study-says/